Exploring the Impact of Obesity on Progression and Prognosis in Early-Stage Endometrioid Endometrial Carcinoma.
Authors:
Open Access
- 5 September 2025
- journal article
- Vol. 6 (1) , 803-815
Abstract
Endometrioid endometrial carcinoma (EEC) is the most prevalent malignancy affecting the female reproductive system, and obesity is a significant risk factor. In this study, we examined the influence of saturated fatty acids (SFAs) on early-stage EEC progression. A two-sample Mendelian randomization (MR) analysis using single-nucleotide polymorphisms as instrumental variables was used to assess the potential causal associations among body mass index (BMI), the main components of adipose tissue, and EEC. Clinical data from 231 patients with EEC at Benxi Central Hospital were analyzed according to BMI categories. CCK-8, apoptosis, cell cycle, scratch, and transwell assays were used to examine the biological behavior of Ishikawa cells treated with palmitic acid (PA), the main SFA component. GraphPad Prism v10.2.0 was employed to perform correlation analysis. MR analysis revealed a statistically causal relationship between BMI and EEC (inverse variance weighted, p = 3.573 × 10-7). Furthermore, SFAs (inverse variance weighted, p = 0.032) and triglycerides (inverse variance weighted, p = 0.036) played a notable role in the influence of BMI, and a high BMI was correlated with cervical invasion risk (p < 0.001). PA promoted Ishikawa cell proliferation at 24 hours and significantly enhanced migration and invasion at 48 hours. This research highlights the clinical significance and implications of BMI in the evaluation of poor prognosis in early-stage EEC and the potential role of SFAs in the proliferative, migratory, and invasive abilities of EEC. Our findings emphasize the importance of dietary weight management, particularly for patients with stage I EEC.Keywords
This publication has 42 references indexed in Scilit:
- Emerging Biological Principles of MetastasisCell, 2017
- Obesity and Endometrial Cancer2016
- Body Fatness and Cancer — Viewpoint of the IARC Working GroupNew England Journal of Medicine, 2016
- Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC CohortsClinical Cancer Research, 2016
- Dual blockade of PI3K/AKT/mTOR (NVP-BEZ235) and Ras/Raf/MEK (AZD6244) pathways synergistically inhibit growth of primary endometrioid endometrial carcinoma cultures, whereas NVP-BEZ235 reduces tumor growth in the corresponding xenograft modelsGynecologic Oncology, 2015
- Subcutaneous Adipocytes Promote Melanoma Cell Growth by Activating the Akt Signaling PathwayJournal of Biological Chemistry, 2014
- Expression of ki‐67 as proliferation biomarker in imprint smears of endometrial carcinomaDiagnostic Cytopathology, 2011
- Treatment effects, disease recurrence, and survival in obese women with early endometrial carcinomaCancer, 2006
- Insulin and glucose status, tissue and plasma lipids in patients with tumours of the ovary or endometrium: possible dietary implicationsBritish Journal of Cancer, 1994
- Two pathogenetic types of endometrial carcinomaGynecologic Oncology, 1983